210 related articles for article (PubMed ID: 15494398)
21. Apparent formation of sodium dodecyl sulfate-stable complexes between serpins and 3,4-dichloroisocoumarin-inactivated proteinases is due to regeneration of active proteinase from the inactivated enzyme.
Olson ST; Swanson R; Patston PA; Björk I
J Biol Chem; 1997 May; 272(20):13338-42. PubMed ID: 9148956
[TBL] [Abstract][Full Text] [Related]
22. Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro.
Pasternack MS; Bleier KJ; McInerney TN
J Biol Chem; 1991 Aug; 266(22):14703-8. PubMed ID: 1860869
[TBL] [Abstract][Full Text] [Related]
23. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
24. Synthetic substrates and inhibitors for serine proteases from lymphocytes, mast cells, semen, and blood.
Powers JC; Odake S; Ueda T; Hudig D; Graves HC; Kamarei M; Kam CM
Agents Actions Suppl; 1992; 38 ( Pt 2)():128-35. PubMed ID: 1462821
[TBL] [Abstract][Full Text] [Related]
25. Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors.
Tremblay GM; Wolbink AM; Cormier Y; Hack CE
J Immunol; 2000 Oct; 165(7):3966-9. PubMed ID: 11034405
[TBL] [Abstract][Full Text] [Related]
26. Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma.
Wilharm E; Parry MA; Friebel R; Tschesche H; Matschiner G; Sommerhoff CP; Jenne DE
J Biol Chem; 1999 Sep; 274(38):27331-7. PubMed ID: 10480954
[TBL] [Abstract][Full Text] [Related]
27. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes.
Edwards KM; Kam CM; Powers JC; Trapani JA
J Biol Chem; 1999 Oct; 274(43):30468-73. PubMed ID: 10521426
[TBL] [Abstract][Full Text] [Related]
28. Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies.
Smyth MJ; O'Connor MD; Trapani JA
J Leukoc Biol; 1996 Nov; 60(5):555-62. PubMed ID: 8929545
[TBL] [Abstract][Full Text] [Related]
29. Expression of enzymatically active human granzyme 3 in Escherichia coli for analysis of its substrate specificity.
Hirata Y; Inagaki H; Shimizu T; Li Q; Nagahara N; Minami M; Kawada T
Arch Biochem Biophys; 2006 Feb; 446(1):35-43. PubMed ID: 16405860
[TBL] [Abstract][Full Text] [Related]
30. Role of the P2 residue in determining the specificity of serpins.
Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
[TBL] [Abstract][Full Text] [Related]
31. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
[TBL] [Abstract][Full Text] [Related]
32. Electrostatic reversal of serine proteinase substrate specificity.
Caputo A; Parrish JC; James MN; Powers JC; Bleackley RC
Proteins; 1999 Jun; 35(4):415-24. PubMed ID: 10382669
[TBL] [Abstract][Full Text] [Related]
33. Definition of the extended substrate specificity determinants for beta-tryptases I and II.
Harris JL; Niles A; Burdick K; Maffitt M; Backes BJ; Ellman JA; Kuntz I; Haak-Frendscho M; Craik CS
J Biol Chem; 2001 Sep; 276(37):34941-7. PubMed ID: 11438529
[TBL] [Abstract][Full Text] [Related]
34. Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor.
Lazarczyk M; Dziunycz P; Niderla J; Milewski L; Lazarczyk MA; Boszczyk A; Samaha R; Grzela T
Int J Mol Med; 2006 Jan; 17(1):135-9. PubMed ID: 16328022
[TBL] [Abstract][Full Text] [Related]
35. NSP4, an elastase-related protease in human neutrophils with arginine specificity.
Perera NC; Schilling O; Kittel H; Back W; Kremmer E; Jenne DE
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6229-34. PubMed ID: 22474388
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).
Groutas WC; Ruan S; Kuang R; Hook JB; Sands H
Biochem Biophys Res Commun; 1997 Apr; 233(3):697-9. PubMed ID: 9168917
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of two serine protease inhibitors expressed in the pituitary gland.
Fell B; Smith AM; Hill RM; Parmar PK; Coates LC; Mezey E; Birch NP
Arch Physiol Biochem; 2002 Apr; 110(1-2):26-33. PubMed ID: 11935397
[TBL] [Abstract][Full Text] [Related]
38. Expression of human recombinant granzyme A zymogen and its activation by the cysteine proteinase cathepsin C.
Kummer JA; Kamp AM; Citarella F; Horrevoets AJ; Hack CE
J Biol Chem; 1996 Apr; 271(16):9281-6. PubMed ID: 8621589
[TBL] [Abstract][Full Text] [Related]
39. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
Peterson FC; Gettins PG
Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
[TBL] [Abstract][Full Text] [Related]
40. A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.
Andrade F; Casciola-Rosen LA; Rosen A
Mol Cell Biol; 2003 Sep; 23(17):6315-26. PubMed ID: 12917351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
